Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics
Authors
Keywords
-
Journal
JNCI-Journal of the National Cancer Institute
Volume 102, Issue 21, Pages 1637-1652
Publisher
Oxford University Press (OUP)
Online
2010-10-19
DOI
10.1093/jnci/djq361
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ALDHhigh adenoid cystic carcinoma cells display cancer stem cell properties and are responsible for mediating metastasis
- (2010) Shuyang Sun et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase
- (2010) Matthew R. Clay et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers
- (2010) Shan Deng et al. PLoS One
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer
- (2009) E. Charafe-Jauffret et al. CLINICAL CANCER RESEARCH
- ABC Transporters, Drug Resistance, and Cancer Stem Cells
- (2009) Michael Dean JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
- (2009) C. J. Creighton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment
- (2009) G. Bertolini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes
- (2008) A M Calcagno et al. BRITISH JOURNAL OF CANCER
- Breast cancer cells expressing stem cell markers CD44+ CD24lo are eliminated by Numb-1 peptide-activated T cells
- (2008) Takashi Mine et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A Human Breast Cell Model of Preinvasive to Invasive Transition
- (2008) A. Rizki et al. CANCER RESEARCH
- Aldehyde dehydrogenase activity as a functional marker for lung cancer
- (2008) Deniz Ucar et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Prognostic relevance of glucosylceramide synthase (GCS) expression in breast cancer
- (2008) Eugen Ruckhäberle et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Melanoma Stem Cells: The Dark Seed of Melanoma
- (2008) Susan E. Zabierowski et al. JOURNAL OF CLINICAL ONCOLOGY
- Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
- (2008) X. Li et al. JNCI-Journal of the National Cancer Institute
- HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
- (2008) H Korkaya et al. ONCOGENE
- Drug-Selected Human Lung Cancer Stem Cells: Cytokine Network, Tumorigenic and Metastatic Properties
- (2008) Vera Levina et al. PLoS One
- Expression of CD133-1 and CD133-2 in ovarian cancer
- (2007) G. FERRANDINA et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Overexpression of glucosylceramide synthase in associated with multidrug resistance of leukemia cells
- (2007) Ping Xie et al. LEUKEMIA RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started